Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)

Clinical trial NCT00494299 · COMPLETED

Trial details

NCT number: NCT00494299
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2006-04-01
Primary completion: 2009-07-01
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.